chrisvoncsefalvay/vaers-outcomes huggingface dataset:
diagnosed her with either cellulitis or an infection as a result of the vaccine; diagnosed her with either cellulitis or an infection as a result of the vaccine; terrible arm pain; diffuse red mark along her arm and in the middle there is like a triangular black and blue spot; It is (Pain) now getting worse over the past few days; This is a spontaneous report received from a contactable consumer or other non-healthcare professional (Parent).    A 26-years-old female patient received bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection and Batch no/ Lot number: FF8841) via an unspecified route of administration on 09Oct2021 (age at vaccination 26 years old) as dose 3 (booster), single for covid-19 immunization. Medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch No. /Lot Number: not reported) administered via an unspecified route on an unspecified date as dose 1 and dose 2 both as single for covid-19 immunization. It was reported that caller daughter had the booster dose of the COVID vaccine on 09Oct2021. On 09Oct201, patient has had terrible arm pain started at night since then, by next day it was full blown, now getting worse over the past few days and also has a diffuse red mark along her arm and in the middle, there was like a triangular black and blue spot. Parent confirmed that the marks that her daughter developed on her arm developed on that same day as well on 09Oct2021. Patient has had two virtual emergency room visits the past two nights because it has gotten that bad. It got worse so her daughter also went to urgent care and on an unknown date patient was diagnosed with either cellulitis or an infection as a result of the vaccine. The Investigation assessment is reported as No. Therapeutic measures taken for the events diagnosed as cellulitis or an infection as a result of the vaccine which included as patient was now on antibiotics. Outcome of the events terrible arm pain and diffuse red mark along her arm and in the middle, there is like a triangular black and blue spot was reported was not recovered and cellulitis or an infection as a result of the vaccine, it was (Pain) now getting worse over the past few days was reported as unknown.  No follow-up attempts are possible. No further information is expected.
Itchy rash on her chest a day after her first dose on 3-22-2021. Worse rash on her chest and lower back (small red rash with some raised wheal) after the second vaccine on 4-14-21.
immed swelling, radiating from inj site;approx 3 inches above & below inj site;area of swelling, red & warm to touch;pt c/o dizziness & feeling faint;pt assisted to floor elevated legs BP & P WNL;ice applied to swelling area;
This spontaneous report was received from a pharmacist and refers to a patient of an unknown age and gender. The patient's relevant medical history, concurrent condition and concomitant medication were not reported. On 19-JUL-2016, the patient was vaccinated with "about half" of the dose of ZOSTAVAX vial 19400 PFU, lot # L032403 (expiry date: 26-NOV-2016), subcutaneously. No adverse effect reported. No Product Quality Complaint (PQC) was involved. Follow up information was received from the pharmacist on 19-SEP-2016. The patient was a 60-year old female of unknown occupation and race. The patient's concurrent conditions included morphine allergy. No concomitant medications pertinent to the events were reported. ZOSTAVAX was purchased with public funds and the patient was vaccinated at a pharmacy on 19-JUL-2016 at about 17:00 in the left arm. It was the patient's first dose of ZOSTAVAX. The patient had no laboratory tests performed, illnesses at time of vaccination or adverse events prior to vaccination. It was reported that the syringe leaked and the patient received partial dose of ZOSTAVAX. A signed informed consent was obtained. Additional information is not expected as all relevant information has already been received. Report's and patient's details, products, events and narrative were updated.
The patient developed a 1.5cm circular area of erythema and warmth at the injection site.
1st dose 2019, not yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 88-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in 2019).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 06-DEC-2022 Reporter's Comment: The pharmacist reported that the patient wanted to schedule a second dose of Shingrix but that the first dose had been received on year 2019.  According to the patient, the first dose was received in 2009 even though Shingrix was approved later. Information on first dose was not available since it was administered in another facility. The vaccine administration facility was the same as primary reporter. The VAERS details given for the first dose of Shingrix. The reporter consented to follow up. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
red flu 6PM-neck aches-7:30 102 fever, chills-muscle spasms in back-asthma attacks-APAP-now 100.6 fever-feel like full fledged flu;
Patient began to feel dizzy and appeared pale to the technician. She was asked how she was doing, and just before responding she collapsed. Patient regained consciousness almost immediately and refused the ambulance. She reported feeling hot and thirsty, water was given and patient's blood pressure was taken. It read 98/67. It was checked again in 20 minutes and increased to 114/82
My whole body ached a few hours after injection, I become nauseous and vomited, and I had chills. The next day I had a bad migraine.
Patient received Moderna booster, gave 0.5 mL instead of 0.25 mL.
Information has been received from an 81 year old female pt, born on 12/27/1920, who was vaccinated with Fluzone SV '2002-'2003 USP on 10/17/02. The day after vaccination, she felt weak-had no strength. She was admitted to hospital on 10/20/02 and was discharged the next day. The outcome of the event was not reported.
right deltoid indurated mass 3cm x 3cm, mild erythema, non tender;
Due to previous reactions to other vaccines per doctor?s suggestion took Quercetin (antihistamine) few days prior through few days after vaccine.  After stopped antihistamine, began experiencing paresthesia throughout my body and have had strong histamine reactions to oxalate containing foods that previously never had issues with.  Have never had these issues before.  Had to get a prescription for an EpiPen which I?ve never needed previously.
fever; headache; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a several patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever and headache. On an unknown date, the outcome of the fever and headache were unknown.   It was unknown if the reporter considered the fever and headache to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not applicable. After receiving Shingrix, some patients experienced fever or headache. This case was linked with case US2020171331, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020171331:same reporter
Fever 101.5 which did not come down 45 min after 500mg Tylenol, body aches, chills, weakness
A non-serious spontaneous report of colds and low grade fever has been received from a consumer concerning an adult female subsequent to H1N1, Intranasal. Neither relevant medical history nor concomitant medications have been reported for this patient. On 17-Oct-2009, the patient received a single dose of H1N1. On 17-Oct-2009, the patient experienced a low grade fever and colds (on and off). The events of low grade fever and colds resolved.
Fever up to 102 only lasted 2 days. Excruciating bone pain throughout spine lower back, hips, tops of thighs. This pain has lasted about three to four days and resolved on its own with Tylenol heating pads and hot baths. I did not seek other medical care during the first vaccination. The second vaccine had the same adverse effects, except the bone pain has not gone away and it continues to this very current day. The bone pain was even worse and with the second vaccine the bone pain needed to be treated with gabapentin through the care of my rheumatologist and needed to be followed up with visits with my rheumatologist after a visit to the emergency department, where it was determined that it was an immune system reaction.
2nd dose moderna given too early 1st dose given 01/21/2021-2nd dose given 02/11/2021- waited 30 min. with no adverse reactions noted - phone call to  pt.02/12/2021 -unable to reach pt. -left message
Allergic reaction and infection at the site, given antibiotics to treat area. Rx AUGMENTIN 875 mg oral tablets. 1 tab by mouth every 12 hrs for 7 days.
Situation: Pt vomitted at 1320 post vaccination.  Background : Patient present for 1st dose of  MODERNA 6mo - 5y/o vaccine with parents on 08/04/2022 for 1300 appointment. Patient agitated at check in and becomes more so when seeing staff, pointing and then crying. Patient received vaccine shot at 1311. Patient was crying and screaming during entire visit. Patient vomitted at 1320, I heard it and then I began my assessment. Parents stated that Patient, "Doesn't like doctor visits and doesn't do well in enclosed areas." Parents also stated that the agitation, crying, and vomitting were all normal of Patient during doctors visits. Parents started breastfeeding Patient after vomitting stating that it calms him down. Parents requested to wait outside in hallway to further ease patient. Original discharge time was 1326 but parents agreed to 15 minutes of extended observation.   Assessment: After breastfeeding, patient started to calm down and stopped crying. Afterwards patient moved to hallway to complete observation period. Vitals at 1334 o2 97% HR 83. BP not obtained because of patient moving and also uncuffing self after 3 tries. Airway patent. Patient calm and relaxed. No redness or rashes seen during assessment.  Recommendation: After vitals were performed and patient was calm, staff suggested that if he begins to cry and vomit again that he should be brought to urgent care. Parent declined and said that they will be going home.  PCP notified as FYI
The injection site became very sensitive; lymph node swelling/lymph node inflammation; Injection site red; Injection site scratchy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INJECTION SITE HYPERSENSITIVITY (The injection site became very sensitive), LYMPHADENOPATHY (lymph node swelling/lymph node inflammation), INJECTION SITE ERYTHEMA (Injection site red) and INJECTION SITE PRURITUS (Injection site scratchy) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event history).    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jan-2021, the patient experienced INJECTION SITE HYPERSENSITIVITY (The injection site became very sensitive), LYMPHADENOPATHY (lymph node swelling/lymph node inflammation), INJECTION SITE ERYTHEMA (Injection site red) and INJECTION SITE PRURITUS (Injection site scratchy). At the time of the report, INJECTION SITE HYPERSENSITIVITY (The injection site became very sensitive), LYMPHADENOPATHY (lymph node swelling/lymph node inflammation), INJECTION SITE ERYTHEMA (Injection site red) and INJECTION SITE PRURITUS (Injection site scratchy) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient has a medical history was not provided. No relevant concomitant medication was reported.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This is a spontaneous report received from a field representative on the after hours line on 14-MAR-2017 who received information from a physician who reported that an unspecified male patient, currently in his 60s had a dose of ZOSTAVAX a "couple of years ago" (lot number not reported). The physician noted that the patient now has a current case of the shingles and is very uncomfortable. No further details were reported. Causality was not reported. Additional information has been requested.
Shortly after patient received an injection patient felt dizzy and fainted. Patient never lost consciousness. Patient promptly sat down and paramedics were called for evaluation. After evaluation patient was able to go home.
From what I'm reading it's covid arm.    4/5/21 morning my left armpit/lymph node hurt.  4/5/21 evening started to see red rash.  4/6/21 rash continues to spread and is painful to the touch and itchy.
Body aches, fatigue, cold chills, headache, nausea. Started evening of vaccine. Worse the next day.
Patient reported some odd body jerking that night when she laid down to go to bed. Also some arm soreness which I told her was normal.
fever, chills, fatigue, nausea, muscle pain, joint pain - ten times worse than last vaccine - I couldn't even close my hands, headaches - that turned into migraines; blurred vision; shortness of breath; heavy chested. Diagnosed me with Thoriatic Arthritis - and put me on meds for that as I was having trouble functioning. Taltz medication is what they've put me on - it's an injection I give myself. I do so many for so long and then I cut back after that.  I will be seeing my doctor again this Wednesday for more follow up.
Chest pain, dyspnea, Supraventricular Tachycardia.  Transported by ambulance to ER.  Adenosine given in ambulance and ER as well as two IV push Cardizem and a cardizem drip for 12 hrs.  HR 240-260.  Admitted to cardiac unit and changed to metoprolol BID.  Discharged on Metoprolol on 11/18/2009 with a future stress test.  12/7/2009 DC summary for 2/13-2/16/2008, patient admitted for depression with medication overdose. 12/8/2009 MR and DC summary for 11/16-11/18/2009 and  11/27-11/30/2009 patient with c/o's tachycardia, pulse 250, tx'd with betablockers, cardiac monitoring, Cardio consult, DC Dx tachycardia
HA, slight nausea, Lt deltoid swollen, pain, 3 cm red, warm 101412 tried ice to reduce swell, warmth, pain decreased. 20 min ice then itch w/in 3 cm red area BENADRYL x 3 das w/ itch subsiding 101412 itch only at injection site if rubbed ie when applying lotion over area.
Sore joints in upper arm. Patient also works in meat/deli department. Lifts and slices meats so also wondered if from this. Site looks fine.
Approx 5-7 mins post/vax, pt's face became splotchy w/reddened areas. Pt given Atarax, within 10-12 mins of dose given, child is asymptomatic. No other symptoms noted; pt observed for 1 hr & discharged home w/instructions.
Really bad muscle spasm which went in her right calf, right foot, left upper thigh and right hand by thumb; She is either rocking her leg or walking around/To the point where she can't sit still,; Fever; Chills; Body ache; This spontaneous case was reported by an other health care professional and describes the occurrence of MUSCLE SPASMS (Really bad muscle spasm which went in her right calf, right foot, left upper thigh and right hand by thumb), MOBILITY DECREASED (She is either rocking her leg or walking around/To the point where she can't sit still,), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body ache) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008D21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (In May).    On 24-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jul-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body ache). On 26-Jul-2021, the patient experienced MUSCLE SPASMS (Really bad muscle spasm which went in her right calf, right foot, left upper thigh and right hand by thumb) and MOBILITY DECREASED (She is either rocking her leg or walking around/To the point where she can't sit still,). At the time of the report, MUSCLE SPASMS (Really bad muscle spasm which went in her right calf, right foot, left upper thigh and right hand by thumb) and MOBILITY DECREASED (She is either rocking her leg or walking around/To the point where she can't sit still,) had not resolved and PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. The Patient had been drinking lot of water and Gatorade.
Information has been received from a physician concerning a 2-month-old female who in approximately February 2008 ("at two months of age"), was vaccinated orally with a second dose of ROTATEQ.  On an unspecified date, post vaccination, the patient experienced bloody stools.  The patient was taken to the emergency room but was not admitted.  It was reported that intussusception was ruled-out.  The patient had only one occurrence of bloody stools.  On an unspecified date the patient recovered.  A product quality complaint was not involved.  Upon internal review "bloody stools" was considered an other medically important event (OME).  Additional information has been requested.
Temp 103 degrees, seizure 9/18/03, took to ER. Diagnosis at ER - febrile seizure, viral syndrome.
Covid vaccination arm- red, raised area at the injection site which showed up 9 days after receiving the vaccine.
Presented to the ED  on 9/21/21 from NH for confusion x3-4 days, found to have covid pneumonia. Vitals remarkable for tachycardia, SBP >170, afebrile, Saturating 91% on room air, later requiring 4L. Labs remarkable for sodium 152, Cl 124, SCR 1.40, AST/ALT 46/120, alk phos 143, glucose 275, troponin 0.091, Hgb 17.6, dimer 1.16, CRP 114, PCT 0.42. ABG ph 7.431, PO2 50.8, PCO2 28.4, bicarb 19.9. CT PE negative for PE, consistent with covid pneumonia, cholelithiasis.    Patient started on dexamethsone and remdesivi, but d/c'ed after three doses as doing well on room air. Started on rocephin and azith, which were discontinued at discharge. Dishcarged on 9/24/21
Employee states about 30 minutes after injection he started feeling dizziness, the symptoms lasted about a day and a half including headache, irritability, light sensitivity.
101 degree fever, extreme fussiness which is very out of character for child, wanted to go to bed an hour early.  Fever lasted 2 days on and off, next came red spots all over body that lasted 2-3 days, still extremely fussy.  As of date of this submission 2/9/15 she is otherwise in good health but extremely fussy and it is very out of character for her.
Swollen lymph node; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 16:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no allergies to medications, food, or other products. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 16:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021, the patient underwent PCR test for COVID-19 and the result was negative. On 14Apr2021, the patient experienced swollen lymph node at upper left chest near neck. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event swollen lymph node was not resolved at the time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
30 minutes after receiving the vaccine- -- hot flashes that lasted 8 hours. Right away after receiving the vaccine-- stiff neck on the left side which after a night's sleep, moved to my right side of neck. No big deal.     Tired & 'drunk' after the vaccine which lasted until mid-afternoon the next day.  No big deal.       The worst of all happened at 3 1/2 days, a rash started in the evening, went to bed, woke up the next day with rash almost everywhere. Red, swollen, & itching like crazy.   The next day- Sunday, along with Monday & Tues. was horrid. I am covered from my scalp to the tops of my feet, my crotch hurts, as do my breasts. Used Benadryl cream, aloe vera to no avail.
Red area on right thigh approximately 1-2cm in diameter not warm to touch, mother and father states "no fever, shows no signs of pain or does not act like it bothers him" states have held warm/cold compress on area. I marked the area with ink pen, instructed parents if redness spreads outside of area marked, if child begins to run a fever, acts like he is not feeling well, or area gets warm to touch take to urgent care or PCP. Parents verbalized understanding. Mother states will call back on Monday and give update.
12/14/22 presents to ED for "shortness of breath". PMHx of "DM, HTN, CKD, hypothyroidism, CHF, AFib"
30 minutes after the vaccine patient developed body aches and chills. He had his blood drawn at that time as part of a routine office visit which showed at elevation in his white blood cells (see below). His condition continued to worsen (feeling more ill) at home and he was sent back to Urgent Care for a recheck. At this point his kidney and liver function tests had deteriorated (see below) and his leukocytosis had increased to 41.27 (see below). Hematology was consulted by Dr. the Urgent Care physician for Clinic and they advised him this was most likely an adverse reaction to the vaccine. Currently patient is having a new symptom of rectal bleeding and we cannot reach him by phone to check on his status. We may send police to his home if no answer to our emails and calls by closing today. If condition worsens he may be directed to the Emergency Department.
About 30 minutes following vaccination pt started hot, dizzy, and followed with throat pain with a headache about 2 after vaccination. Pt reported to medical about 4 hours after vaccination to be evaluated. She was treated with one 0.3mg  Epinephrine auto-injector.